These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1970363)

  • 1. Effects of protein binding and experimental disease states on brain uptake of benzodiazepines in rats.
    Lin TH; Lin JH
    J Pharmacol Exp Ther; 1990 Apr; 253(1):45-50. PubMed ID: 1970363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain uptake of benzodiazepines: effects of lipophilicity and plasma protein binding.
    Jones DR; Hall SD; Jackson EK; Branch RA; Wilkinson GR
    J Pharmacol Exp Ther; 1988 Jun; 245(3):816-22. PubMed ID: 3385643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of blood-brain barrier permeability to DL-propranolol by serum from acute renal failure rats.
    Lin TH; Sawada Y; Sugiyama Y; Iga T; Hanano M
    Biochem Pharmacol; 1987 Oct; 36(20):3425-31. PubMed ID: 3675605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone.
    Pardridge WM; Mietus LJ
    J Clin Invest; 1979 Jul; 64(1):145-54. PubMed ID: 447850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-protein binding and blood-brain barrier permeability.
    Tanaka H; Mizojiri K
    J Pharmacol Exp Ther; 1999 Mar; 288(3):912-8. PubMed ID: 10027826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-brain barrier permeability and in vivo activity of partial agonists of benzodiazepine receptor: a study of L-663,581 and its metabolites in rats.
    Lin JH; Chen IW; Lin TH
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1197-202. PubMed ID: 7996426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of blood components on the tissue uptake indices of cyclosporin in rats.
    Lemaire M; Pardridge WM; Chaudhuri G
    J Pharmacol Exp Ther; 1988 Feb; 244(2):740-3. PubMed ID: 3346845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of route of input on the hepatic disposition of diazepam.
    Sahin S; Rowland M
    J Pharmacol Exp Ther; 2000 Nov; 295(2):836-43. PubMed ID: 11046126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma binding and transport of diazepam across the blood-brain barrier. No evidence for in vivo enhanced dissociation.
    Dubey RK; McAllister CB; Inoue M; Wilkinson GR
    J Clin Invest; 1989 Oct; 84(4):1155-9. PubMed ID: 2794052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of alpha-1-acid glycoprotein, albumin and palmitic acid on the brain and salivary gland extraction of warfarin in rats.
    Urien S; Morin D; Tillement JP
    J Pharmacol Exp Ther; 1989 Feb; 248(2):781-5. PubMed ID: 2918479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An experimental study of the pharmacokinetic mechanisms for the development of gidazepam tolerance].
    Garibova TL; Zherdev VP; Voronina TA; Kolyvanov GB; Otabekova SG
    Eksp Klin Farmakol; 1993; 56(6):48-50. PubMed ID: 7906580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action and peripheral distribution.
    Arendt RM; Greenblatt DJ; deJong RH; Bonin JD; Abernethy DR; Ehrenberg BL; Giles HG; Sellers EM; Shader RI
    J Pharmacol Exp Ther; 1983 Oct; 227(1):98-106. PubMed ID: 6137558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier.
    Pardridge WM; Triguero D; Yang J; Cancilla PA
    J Pharmacol Exp Ther; 1990 May; 253(2):884-91. PubMed ID: 2338660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biokinetics of a new prodrug gidazepam and its metabolite].
    Andronati SA; Zin'kovskiĭ VG; Totrova MIu; Golovenko NIa; Stankevich EA; Zhuk OV
    Biull Eksp Biol Med; 1992 Jan; 113(1):45-7. PubMed ID: 1356504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of age, body composition, and lipid solubility on benzodiazepine tissue distribution in rats.
    Scavone JM; Friedman H; Greenblatt DJ; Shader RI
    Arzneimittelforschung; 1987 Jan; 37(1):2-6. PubMed ID: 2882760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An analysis of the ionic regulation of the specific binding of 3H-diazepam depending on the phenotype of the emotional stress reaction].
    Seredenin SB; Blednov IuA; Nagovitsina IuA
    Biull Eksp Biol Med; 1992 Nov; 114(11):459-61. PubMed ID: 1363278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of benzodiazepine brain uptake: lipophilicity versus binding affinity.
    Arendt RM; Greenblatt DJ; Liebisch DC; Luu MD; Paul SM
    Psychopharmacology (Berl); 1987; 93(1):72-6. PubMed ID: 2888155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of specific binding to the central benzodiazepine site to the brain concentrations of two novel benzodiazepine site ligands.
    Pike A; Cook SM; Watt AP; Scott-Stevens P; Rosahl TW; McKernan RM; Pym LJ; Guiblin A; Moyes C; Sohal B; Atack JR
    Biopharm Drug Dispos; 2007 Sep; 28(6):275-82. PubMed ID: 17570124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-brain barrier permeability and bioavailability of a highly potent and mu-selective opioid receptor antagonist, CTAP: comparison with morphine.
    Abbruscato TJ; Thomas SA; Hruby VJ; Davis TP
    J Pharmacol Exp Ther; 1997 Jan; 280(1):402-9. PubMed ID: 8996221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered dose-to-effect of propofol due to pharmacokinetics in rats with experimental diabetes mellitus.
    Leal N; Calvo R; Agrad FZ; Lukas JC; de la Fuente L; Suarez E
    J Pharm Pharmacol; 2005 Mar; 57(3):317-25. PubMed ID: 15807987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.